Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,890 JPY | +2.37% | +2.70% | +22.87% |
May. 22 | Towa Pharmaceutical Co., Ltd. Announces Board and Committee Resignations | CI |
Mar. 25 | Towa Pharmaceutical Completes Payment for Director Stock Compensation | MT |
Sales 2024 | 228B 1.45B | Sales 2025 * | 258B 1.64B | Capitalization | 142B 904M |
---|---|---|---|---|---|
Net income 2024 | 16.17B 103M | Net income 2025 * | 11.86B 75.37M | EV / Sales 2024 | 0.63 x |
Net Debt 2024 * | 163B 1.03B | Net Debt 2025 * | 175B 1.11B | EV / Sales 2025 * | 1.23 x |
P/E ratio 2024 |
8.84
x | P/E ratio 2025 * |
12
x | Employees | 4,298 |
Yield 2024 |
2.07% | Yield 2025 * |
2.08% | Free-Float | 47.46% |
1 day | +2.37% | ||
1 week | +2.70% | ||
1 month | +1.87% | ||
3 months | +3.62% | ||
6 months | +17.00% | ||
Current year | +22.87% |
Managers | Title | Age | Since |
---|---|---|---|
Itsuro Yoshida
PSD | President | 73 | 79-04-30 |
Kenichi Inoue
ADM | Chief Administrative Officer | - | - |
Norikazu Inoue
BRD | Director/Board Member | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Itsuro Yoshida
PSD | President | 73 | 79-04-30 |
Sadayuki Morino
PRN | Corporate Officer/Principal | 70 | 81-08-31 |
Norikazu Eiki
BRD | Director/Board Member | 76 | 15-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.17% | 19 M€ | +11.22% | ||
0.01% | 9,760 M€ | +18.72% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 2,890 | +2.37% | 92,700 |
24-05-30 | 2,823 | -1.36% | 62,400 |
24-05-29 | 2,862 | -0.42% | 72,100 |
24-05-28 | 2,874 | +0.63% | 87,400 |
24-05-27 | 2,856 | +1.49% | 78,800 |
Delayed Quote Japan Exchange, May 31, 2024 at 02:00 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.87% | 905M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- 4553 Stock